LAURA SHERMAN: Open Payments
NPI 1689703175 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 27 payments from 4 companies in 2025. Trend: 2023 $24 · 2024 $151 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $561 |
| Lundbeck LLC | 4 | $122 |
| Alkermes, Inc. | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: FANAPT, REXULTI, LYBALVI, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
